It has been reported that PGRN contributes to cell proliferation through extracellular signal-regulated kinase (ERK), phosphoinositide 3-kinase (PI3-K), and focal adhesion kinase (FAK) pathways in cancer cells [11]. This evidence concerns the gene PTK2 and cancer.